Welcome to our dedicated page for Equifax SEC filings (Ticker: EFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Equifax Inc. (NYSE: EFX) is a global data, analytics, and technology company whose SEC filings provide detailed insight into its credit reporting, workforce solutions, and compliance businesses. Through its periodic reports and current reports, Equifax discloses information about its financial condition, results of operations, risk factors, and significant corporate events.
On this page, you can review Equifax’s U.S. Securities and Exchange Commission filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its data, analytics, and cloud technology strategy, global operations across 24 countries, and the performance of areas such as consumer credit information and workforce solutions. Current reports on Form 8-K, such as those filed to announce quarterly financial results, provide timely updates on material events affecting the company.
Investors and analysts can also use this page to access other key documents, including proxy materials related to governance and executive compensation and, where applicable, insider transaction reports on Form 4 that show purchases and sales of Equifax securities by directors and officers. These filings help explain how Equifax manages its role as one of the major U.S. credit bureaus and as a provider of employment verification, AML compliance, and cloud-based analytics solutions.
Stock Titan enhances these filings with AI-powered summaries that highlight important sections and clarify complex disclosures. Real-time updates from the SEC’s EDGAR system ensure that new Equifax filings, including 10-Ks, 10-Qs, 8-Ks, and Forms 3 and 4, are available quickly, while AI-generated insights help readers understand the implications of changes in strategy, risk disclosures, and capital allocation for EFX shareholders.
A shareholder has filed a notice of intent to sell 37,791 shares of common stock through Fidelity Brokerage Services LLC, to be sold on the NYSE around 02/10/2026. The filing lists an aggregate market value of about $7,399,855.71 for these shares.
The shares were acquired as a stock option granted on 05/04/2018 and exercised for cash on 02/10/2026. The notice also reports that 122,394,037 shares of this class of stock are outstanding.
Equifax Inc. CEO and director Mark W. Begor reported equity transactions in company common stock dated February 3, 2026. He acquired 59,123 shares of common stock at $0.0000 per share and had 2,405 shares disposed of at $175.05 per share, leaving 198,987 shares directly owned.
The filing also lists indirect holdings in several grantor retained annuity trusts (GRATs), including 10,500, 21,284, 22,045, 12,333 and 16,287 shares of common stock. A footnote explains that the reported direct holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.
Equifax Inc. filed a current report to note that it has released its financial results for the three- and twelve-month periods ended December 31, 2025. The company issued a press release on February 4, 2026, and attached the full text as an exhibit to this report.
The press release, included as Exhibit 99.1, is designated as “furnished” rather than “filed” under securities law, which affects how it is treated for certain liability and incorporation-by-reference purposes. No specific revenue, profit, or other financial figures are detailed in this report itself.
Equifax Inc. CEO and director Form 4 filing details insider share activity. On 12/31/2025, a reporting person had 997 shares of Equifax common stock withheld in a transaction coded "F" at a price of $216.98 per share, typically indicating shares withheld to cover taxes on equity awards. After this transaction, the insider directly beneficially owned 142,091 shares of common stock. The insider also held additional indirect interests through several grantor retained annuity trusts (GRATs), including 10,500 shares in a 2-year 2025 GRAT, 21,284 shares in a 2-year December 2025 GRAT, 22,045 shares in a 2-year June 2025 GRAT, 12,333 shares in a 2-year May 2025 GRAT, and 16,287 shares in a 3-year July 2024 GRAT. The holdings include accrued dividend equivalent units and 199 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan.
Equifax Inc. director reports additional deferred stock-based compensation. A board member of Equifax Inc. (EFX), filing as a director and sole reporting person, recorded an acquisition of 156 phantom stock units on 12/31/2025 under the company’s Board of Directors Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of Equifax common stock and represents fees that the director elected to receive in stock-based form instead of cash annual retainer payments. After this transaction, the director beneficially owns 2,284 phantom stock units held directly. These units are payable, at the director’s election, upon termination of service as a director, meaning the value tracks Equifax’s stock until that time but does not involve immediate cash or share delivery.
Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4. On 11/20/2025, the executive sold 2,500 shares of Equifax common stock at a price of $208.37 per share in an open-market sale coded as "S." The filing notes that these sales were made under a pre-arranged Rule 10b5-1 trading plan adopted on 5/14/2025, which is designed to systematically execute trades. Following this transaction, the executive beneficially owned 59,527 shares of Equifax common stock directly.
EFX has a planned insider sale disclosed on Form 144. A person related to the company intends to sell 2,500 common shares through Fidelity Brokerage Services LLC, with an aggregate market value of 520,925.00, on or around 11/20/2025 on the NYSE. The filing notes that there were 122,394,037 shares outstanding.
The shares to be sold were acquired on 02/23/2024 through restricted stock vesting from the issuer as compensation, and the full 2,500 shares acquired in that transaction are listed for sale. The form also includes a standard representation that the seller is not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Equifax Inc. (EFX) executive reports tax-related share withholding. The company's EVP and Chief HR Officer filed a Form 4 disclosing that on 11/14/2025, 227 shares of Equifax common stock were withheld upon the early vesting of an equal number of restricted stock units to cover taxes associated with the executive becoming retirement eligible. The shares were valued at $204.86 each for this withholding transaction.
After this event, the executive beneficially owned 13,450 shares of Equifax common stock. This total includes accrued dividend equivalent units reinvested in corresponding restricted stock units through the company's last dividend payment date and 270 shares purchased under the Equifax Inc. 2020 Employee Stock Purchase Plan. The transaction reflects routine tax withholding rather than an open-market sale.
Equifax Inc. (EFX) reported an insider transaction by its EVP, CFO & COO on a Form 4. On 11/14/2025, 202 shares of common stock were withheld at a price of $204.86 per share to cover taxes due on the early vesting of an equal number of restricted stock units after the executive became retirement eligible. Following this tax withholding, the reporting person directly beneficially owns 62,027 shares, which include accrued dividend equivalent units from reinvested dividends.
Equifax Inc. executive files Form 4 reporting tax withholding on vested stock units. The company's EVP and Chief Legal Officer reported that on 11/14/2025, 260 shares of Equifax common stock were withheld at a price of $204.86 per share to cover taxes due when an equal number of restricted stock units vested early as the executive became retirement eligible. After this withholding transaction, the reporting person beneficially owned 15,927 shares of Equifax common stock, which include dividend equivalent units that were reinvested in corresponding restricted stock units through the company's most recent dividend payment date.